Rebisci Life Sciences: The company currently does not have any specific vaccines or drugs related to the Nipah virus.

Replibio stated on the interactive platform on January 29 that the company currently does not have any targeted vaccines or drugs against the Nipah virus, and will continue to monitor the dynamics of the virus and assess research and development opportunities reasonably.